Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


18.06.2018

9 AIDS
3 AIDS Res Hum Retroviruses
1 Ann Intern Med
1 Antimicrob Agents Chemother
2 BMC Cancer
1 Br J Dermatol
2 Clin Infect Dis
1 Int J Dermatol
1 J Clin Immunol
1 J Infect Dis
1 J Pediatr
3 J Virol
2 Lancet
15 Lancet HIV
1 MMWR Morb Mortal Wkly Rep
2 N Engl J Med
1 Nat Med
1 PLoS Comput Biol
1 PLoS Med
22 PLoS One
1 PLoS Pathog
2 Proc Natl Acad Sci U S A
2 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. DE LEOTOING L, Yazdanpanah Y, Finkielsztejn L, Chaize G, et al
    Costs Associated with Hospitalisation in Hiv-Positive Patients in France.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001907.
    PubMed     Text format     Abstract available

  2. DE NEVE JW, Karlsson O, Coetzee L, Schroder H, et al
    Antiretroviral therapy coverage associated with increased co-residence between elderly people and prime-age adults in Africa.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001917.
    PubMed     Text format     Abstract available

  3. OSMAN N, Mesplede T, Oliveira M, Hassounah S, et al
    Durable suppression of HIV-1 with resistance mutations to integrase inhibitors by dolutegravir following drug washout.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001903.
    PubMed     Text format     Abstract available

  4. PAPASAVVAS E, Lada SM, Joseph J, Yin X, et al
    Analytical ART interruption does not irreversibly change pre-interruption levels of cellular HIV.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001909.
    PubMed     Text format     Abstract available

  5. D'ELBEE M, Indravudh PP, Mwenge L, Kumwenda MM, et al
    Preferences for linkage to HIV care services following a reactive self-test: discrete choice experiments in Malawi and Zambia.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001918.
    PubMed     Text format     Abstract available

  6. PYRA M, Anderson PL, Hendrix CW, Heffron R, et al
    Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral pre-exposure prophylaxis.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001922.
    PubMed     Text format     Abstract available

  7. HUGHES AJ, Rector A, Jimenez V, Brock J, et al
    Cumulative plasma HIV burden disparities among adults in HIV care: implications for HIV transmission in the era of treatment as prevention.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001914.
    PubMed     Text format     Abstract available

  8. SEATLA KK, Avalos A, Moyo S, Mine M, et al
    Four class drug resistant HIV-1 subtype C in a treatment experienced individual on dolutegravir based antiretroviral therapy in Botswana.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001920.
    PubMed     Text format     Abstract available

  9. XIA Q, Abraham B, Shah D, Ramaswamy C, et al
    Transition from pediatric to adult care among persons with perinatal HIV infection in New York City, 2006-2015.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001923.
    PubMed     Text format     Abstract available


    AIDS Res Hum Retroviruses

  10. PINTO A, Grey P, Shaik A, Cooper DA, et al
    Early treatment of primary HIV infection is associated with decreased mortality.
    AIDS Res Hum Retroviruses. 2018 Jun 14. doi: 10.1089/AID.2017.0284.
    PubMed     Text format     Abstract available

  11. SHARMA A, Overbaugh J
    CD4:HIV-1 Envelope interactions provide critical insights for the SHIV/Macaque model.
    AIDS Res Hum Retroviruses. 2018 Jun 11. doi: 10.1089/AID.2018.0110.
    PubMed     Text format     Abstract available

  12. HILLIER SL, Cummins JE Jr, Rohan LC
    Charlene Susan Dezzutti (1964-2018) Virologist with a Passion for HIV Prevention.
    AIDS Res Hum Retroviruses. 2018;34:475-476.
    PubMed     Text format    


    Ann Intern Med

  13. PARK LS, Tate JP, Sigel K, Brown ST, et al
    Association of Viral Suppression With Lower AIDS-Defining and Non-AIDS-Defining Cancer Incidence in HIV-Infected Veterans: A Prospective Cohort Study.
    Ann Intern Med. 2018 Jun 12. pii: 2684480. doi: 10.7326/M16-2094.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  14. ANKROM W, Yee KL, Sanchez RI, Adedoyin A, et al
    Severe Renal Impairment Has Minimal Impact on Doravirine Pharmacokinetics.
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.00326.
    PubMed     Text format     Abstract available


    BMC Cancer

  15. GININDZA TG, Sartorius B
    Projected cervical Cancer incidence in Swaziland using three methods and local survey estimates.
    BMC Cancer. 2018;18:639.
    PubMed     Text format     Abstract available

  16. BROCCOLI A, Nanni L, Stefoni V, Agostinelli C, et al
    A patient with plasmablastic lymphoma achieving long-term complete remission after thalidomide-dexamethasone induction and double autologous stem cell transplantation: a case report.
    BMC Cancer. 2018;18:645.
    PubMed     Text format     Abstract available


    Br J Dermatol

  17. SUN JR, Tu P, Wang Y
    Image Gallery: Malignant syphilis in a young man with HIV infection.
    Br J Dermatol. 2018;178:e392.
    PubMed     Text format    


    Clin Infect Dis

  18. BENGTSON AM, Pence BW, Mimiaga MJ, Gaynes BN, et al
    Depressive Symptoms and Engagement in HIV Care following ART Initiation.
    Clin Infect Dis. 2018 Jun 12. pii: 5036558. doi: 10.1093.
    PubMed     Text format     Abstract available

  19. CHAMMARTIN F, Zurcher K, Keiser O, Weigel R, et al
    Outcomes of Patients Lost to Follow-up in African Antiretroviral Therapy Programs: Individual Patient Data Meta-analysis.
    Clin Infect Dis. 2018 Jun 8. pii: 5034717. doi: 10.1093.
    PubMed     Text format     Abstract available


    Int J Dermatol

  20. VANGIPURAM R, Tyring SK
    Epidemiology of Kaposi sarcoma: review and description of the nonepidemic variant.
    Int J Dermatol. 2018 Jun 11. doi: 10.1111/ijd.14080.
    PubMed     Text format     Abstract available


    J Clin Immunol

  21. SOLOGUREN I, Martinez-Saavedra MT, Sole-Violan J, de Borges de Oliveira E Jr, et al
    Lethal Influenza in Two Related Adults with Inherited GATA2 Deficiency.
    J Clin Immunol. 2018 Jun 7. pii: 10.1007/s10875-018-0512.
    PubMed     Text format     Abstract available


    J Infect Dis

  22. RAO M, Onkar S, Peachman KK, White Y, et al
    Liposome-Encapsulated HIV-1 gp120 Induces Potent V1V2-Specific Antibodies in Humans.
    J Infect Dis. 2018 Jun 9. pii: 5035293. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Pediatr

  23. ONYANGO DO, Yuen CM, Masini E, Borgdorff MW, et al
    Epidemiology of Pediatric Tuberculosis in Kenya and Risk Factors for Mortality during Treatment: A National Retrospective Cohort Study.
    J Pediatr. 2018 Jun 6. pii: S0022-3476(18)30673.
    PubMed     Text format     Abstract available


    J Virol

  24. BALAMURUGAN A, Ng HL, Yang OO
    Cross-Reactivity Against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones.
    J Virol. 2018 Jun 13. pii: JVI.00617-18. doi: 10.1128/JVI.00617.
    PubMed     Text format     Abstract available

  25. DHARAN A, Campbell EM
    The Role of Microtubules and Microtubule Associated Proteins in HIV-1 Infection.
    J Virol. 2018 Jun 13. pii: JVI.00085-18. doi: 10.1128/JVI.00085.
    PubMed     Text format     Abstract available

  26. CHONG H, Xue J, Zhu Y, Cong Z, et al
    Design of Novel HIV-1/2 Fusion Inhibitors with Efficient Therapeutic Efficacy in Rhesus Monkey Models.
    J Virol. 2018 Jun 13. pii: JVI.00775-18. doi: 10.1128/JVI.00775.
    PubMed     Text format     Abstract available


    Lancet

  27. THE LANCET
    Dolutegravir for HIV: a lesson in pregnancy safety research.
    Lancet. 2018;391:2296.
    PubMed     Text format    

  28. MCBRIDE B, Mitra S, Kondo V, Elmi H, et al
    Unpaid labour, #MeToo, and young women in global health.
    Lancet. 2018;391:2192-2193.
    PubMed     Text format    


    Lancet HIV

  29. LUNDGREN J, Phillips A
    Language used to convey HIV infection risk is important - Authors' reply.
    Lancet HIV. 2018;5:e272.
    PubMed     Text format    

  30. RAGONNET-CRONIN M, Hue S, Hodcroft EB, Tostevin A, et al
    Non-disclosed men who have sex with men in UK HIV transmission networks: phylogenetic analysis of surveillance data.
    Lancet HIV. 2018;5:e309-e316.
    PubMed     Text format     Abstract available

  31. BAROUCH DH
    A step forward for HIV vaccines.
    Lancet HIV. 2018 Jun 8. pii: S2352-3018(18)30095.
    PubMed     Text format    

  32. BEKKER LG, Moodie Z, Grunenberg N, Laher F, et al
    Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.
    Lancet HIV. 2018 Jun 8. pii: S2352-3018(18)30071.
    PubMed     Text format     Abstract available

  33. DUNN DT, Glidden DV, Stirrup OT, McCormack S, et al
    The averted infections ratio: a novel measure of effectiveness of experimental HIV pre-exposure prophylaxis agents.
    Lancet HIV. 2018;5:e329-e334.
    PubMed     Text format     Abstract available

  34. PITMAN MC, Lau JSY, McMahon JH, Lewin SR, et al
    Barriers and strategies to achieve a cure for HIV.
    Lancet HIV. 2018;5:e317-e328.
    PubMed     Text format     Abstract available

  35. JOSE S, Delpech V, Howarth A, Burns F, et al
    A continuum of HIV care describing mortality and loss to follow-up: a longitudinal cohort study.
    Lancet HIV. 2018;5:e301-e308.
    PubMed     Text format     Abstract available

  36. HOLT E
    The Alliance for Public Health, Ukraine.
    Lancet HIV. 2018;5:e276.
    PubMed     Text format    

  37. LEAHY B
    Language used to convey HIV infection risk is important.
    Lancet HIV. 2018;5:e272.
    PubMed     Text format    

  38. SULLIVAN PS, Oster AM
    Phylogenetic analyses of local HIV transmission.
    Lancet HIV. 2018;5:e270-e271.
    PubMed     Text format    

  39. HOGG RS
    Understanding the HIV care continuum.
    Lancet HIV. 2018;5:e269-e270.
    PubMed     Text format    

  40. THE LANCET HIV
    HIV status disclosure in a digital age.
    Lancet HIV. 2018;5:e265.
    PubMed     Text format    

  41. PHANUPHAK N, Phanuphak P
    Time to focus more on condomless anal sex in non-PrEP users.
    Lancet HIV. 2018 Jun 6. pii: S2352-3018(18)30100.
    PubMed     Text format    

  42. HOLT M, Lea T, Mao L, Kolstee J, et al
    Community-level changes in condom use and uptake of HIV pre-exposure prophylaxis by gay and bisexual men in Melbourne and Sydney, Australia: results of repeated behavioural surveillance in 2013-17.
    Lancet HIV. 2018 Jun 6. pii: S2352-3018(18)30072.
    PubMed     Text format     Abstract available

  43. DORWARD J, Lessells R, Drain PK, Naidoo K, et al
    Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research.
    Lancet HIV. 2018 Jun 5. pii: S2352-3018(18)30093.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  44. MACKELLAR D, Williams D, Bhembe B, Dlamini M, et al
    Peer-Delivered Linkage Case Management and Same-Day ART Initiation for Men and Young Persons with HIV Infection - Eswatini, 2015-2017.
    MMWR Morb Mortal Wkly Rep. 2018;67:663-667.
    PubMed     Text format     Abstract available


    N Engl J Med

  45. MULASI I
    The Scarlet Virus.
    N Engl J Med. 2018;378:2157-2159.
    PubMed     Text format    


  46. Extended Antiretroviral Prophylaxis to Reduce Breast-Milk HIV-1 Transmission.
    N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMx180021.
    PubMed     Text format    


    Nat Med

  47. COLBY DJ, Trautmann L, Pinyakorn S, Leyre L, et al
    Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection.
    Nat Med. 2018 Jun 11. pii: 10.1038/s41591-018-0026.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  48. DUWAL S, Dickinson L, Khoo S, von Kleist M, et al
    Hybrid stochastic framework predicts efficacy of prophylaxis against HIV: An example with different dolutegravir prophylaxis schemes.
    PLoS Comput Biol. 2018;14:e1006155.
    PubMed     Text format     Abstract available


    PLoS Med

  49. FOX MP, Bor J, Brennan AT, MacLeod WB, et al
    Estimating retention in HIV care accounting for patient transfers: A national laboratory cohort study in South Africa.
    PLoS Med. 2018;15:e1002589.
    PubMed     Text format     Abstract available


    PLoS One

  50. BADEJO OA, Menson WNA, Sam-Agudu NA, Pharr J, et al
    Pediatric to adult healthcare transitioning for adolescents living with HIV in Nigeria: A national survey.
    PLoS One. 2018;13:e0198802.
    PubMed     Text format     Abstract available

  51. OURSLER KK, Sorkin JD, Ryan AS, Katzel LI, et al
    A pilot randomized aerobic exercise trial in older HIV-infected men: Insights into strategies for successful aging with HIV.
    PLoS One. 2018;13:e0198855.
    PubMed     Text format     Abstract available

  52. COETZEE LM, Cassim N, Sriruttan C, Mhlanga M, et al
    Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts <100 cells/mul identifies districts in South Africa with advanced burden of disease.
    PLoS One. 2018;13:e0198993.
    PubMed     Text format     Abstract available

  53. GAMAGE S, Howard M, Makita H, Cross B, et al
    Probing structural changes in single enveloped virus particles using nano-infrared spectroscopic imaging.
    PLoS One. 2018;13:e0199112.
    PubMed     Text format     Abstract available

  54. GHOSH M, Daniels J, Pyra M, Juzumaite M, et al
    Impact of chronic sexual abuse and depression on inflammation and wound healing in the female reproductive tract of HIV-uninfected and HIV-infected women.
    PLoS One. 2018;13:e0198412.
    PubMed     Text format     Abstract available

  55. KHAN S, Liomba G, Rosenberg NE, Stanley C, et al
    Utilization of fine needle aspiration cytology at Kamuzu central hospital.
    PLoS One. 2018;13:e0196561.
    PubMed     Text format     Abstract available

  56. KILMARX PH, Gonese E, Lewis DA, Chirenje ZM, et al
    HIV infection in patients with sexually transmitted infections in Zimbabwe - Results from the Zimbabwe STI etiology study.
    PLoS One. 2018;13:e0198683.
    PubMed     Text format     Abstract available

  57. AWUNGAFAC G, Amin ET, Fualefac A, Takah NF, et al
    Viral load testing and the use of test results for clinical decision making for HIV treatment in Cameroon: An insight into the clinic-laboratory interface.
    PLoS One. 2018;13:e0198686.
    PubMed     Text format     Abstract available

  58. NANFUKA EK, Kyaddondo D, Ssali SN, Asingwire N, et al
    Social capital and resilience among people living on antiretroviral therapy in resource-poor Uganda.
    PLoS One. 2018;13:e0197979.
    PubMed     Text format     Abstract available

  59. NEGI BS, Joshi SK, Nakazawa M, Kotaki T, et al
    Impact of a massive earthquake on adherence to antiretroviral therapy, mental health, and treatment failure among people living with HIV in Nepal.
    PLoS One. 2018;13:e0198071.
    PubMed     Text format     Abstract available

  60. OJIKUTU BO, Srinivasan S, Bogart LM, Subramanian SV, et al
    Mass incarceration and the impact of prison release on HIV diagnoses in the US South.
    PLoS One. 2018;13:e0198258.
    PubMed     Text format     Abstract available

  61. ROCHA DFS, Cruz KS, Santos CSDS, Menescal LSF, et al
    MLST reveals a clonal population structure for Cryptococcus neoformans molecular type VNI isolates from clinical sources in Amazonas, Northern-Brazil.
    PLoS One. 2018;13:e0197841.
    PubMed     Text format     Abstract available

  62. TAYLOR WD JR, Langham GL, Weed JL, Rowe T, et al
    The effects of repeated automated plasmapheresis in goats (Capra hircus) in response to vaccination with purified influenza hemagglutinin proteins.
    PLoS One. 2018;13:e0195903.
    PubMed     Text format     Abstract available

  63. KRASHIN JW, Haddad LB, Tweya H, Chiwoko J, et al
    Factors associated with desired fertility among HIV-positive women and men attending two urban clinics in Lilongwe, Malawi.
    PLoS One. 2018;13:e0198798.
    PubMed     Text format     Abstract available

  64. CZAICKI NL, Dow WH, Njau PF, McCoy SI, et al
    Do incentives undermine intrinsic motivation? Increases in intrinsic motivation within an incentive-based intervention for people living with HIV in Tanzania.
    PLoS One. 2018;13:e0196616.
    PubMed     Text format     Abstract available

  65. KINT S, De Spiegelaere W, De Kesel J, Vandekerckhove L, et al
    Evaluation of bisulfite kits for DNA methylation profiling in terms of DNA fragmentation and DNA recovery using digital PCR.
    PLoS One. 2018;13:e0199091.
    PubMed     Text format     Abstract available

  66. KAMI-ONAGA K, Tateyama M, Kinjo T, Parrott G, et al
    Comparison of two screening tests for HIV-Associated Neurocognitive Disorder suspected Japanese patients with respect to cART usage.
    PLoS One. 2018;13:e0199106.
    PubMed     Text format     Abstract available

  67. WARREN EA, Paterson P, Schulz WS, Lees S, et al
    Risk perception and the influence on uptake and use of biomedical prevention interventions for HIV in sub-Saharan Africa: A systematic literature review.
    PLoS One. 2018;13:e0198680.
    PubMed     Text format     Abstract available

  68. TROYA J, Montejano R, Ryan P, Gomez C, et al
    Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study.
    PLoS One. 2018;13:e0198768.
    PubMed     Text format     Abstract available

  69. BOILLAT-BLANCO N, Mbarack Z, Samaka J, Mlaganile T, et al
    Prognostic value of quickSOFA as a predictor of 28-day mortality among febrile adult patients presenting to emergency departments in Dar es Salaam, Tanzania.
    PLoS One. 2018;13:e0197982.
    PubMed     Text format     Abstract available

  70. MANTRI CK, Pandhare Dash J, Mantri JV, Dash C, et al
    Correction: Cocaine Enhances HIV-1 Replication in CD4+ T Cells by Down-Regulating MiR-125b.
    PLoS One. 2018;13:e0199338.
    PubMed     Text format     Abstract available

  71. BEHRENS NE, Wertheimer A, Klotz SA, Ahmad N, et al
    Reduction in terminally differentiated T cells in virologically controlled HIV-infected aging patients on long-term antiretroviral therapy.
    PLoS One. 2018;13:e0199101.
    PubMed     Text format     Abstract available


    PLoS Pathog

  72. ELLETT F, Pazhakh V, Pase L, Benard EL, et al
    Macrophages protect Talaromyces marneffei conidia from myeloperoxidase-dependent neutrophil fungicidal activity during infection establishment in vivo.
    PLoS Pathog. 2018;14:e1007063.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  73. POPOV S, Popova E, Inoue M, Wu Y, et al
    HIV-1 gag recruits PACSIN2 to promote virus spreading.
    Proc Natl Acad Sci U S A. 2018 Jun 11. pii: 1801849115.
    PubMed     Text format     Abstract available

  74. YANG Y, Qu N, Tan J, Rushdi MN, et al
    Roles of Gag-RNA interactions in HIV-1 virus assembly deciphered by single-molecule localization microscopy.
    Proc Natl Acad Sci U S A. 2018 Jun 11. pii: 1805728115.
    PubMed     Text format     Abstract available


    Vaccine

  75. CHESSON HW, Meites E, Ekwueme DU, Saraiya M, et al
    Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26years in the United States.
    Vaccine. 2018 Jun 7. pii: S0264-410X(18)30578.
    PubMed     Text format     Abstract available

  76. TAN N, Sharma M, Winer R, Galloway D, et al
    Model-estimated effectiveness of single dose 9-valent HPV vaccination for HIV-positive and HIV-negative females in South Africa.
    Vaccine. 2018 Jun 8. pii: S0264-410X(18)30197.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: